FI80264C - Foerfarande foer framstaellning av terapeutiskt aktiva imidazolderivat, som aer substituerade med en bisyklisk grupp i 4(5)-staellning. - Google Patents

Foerfarande foer framstaellning av terapeutiskt aktiva imidazolderivat, som aer substituerade med en bisyklisk grupp i 4(5)-staellning. Download PDF

Info

Publication number
FI80264C
FI80264C FI854335A FI854335A FI80264C FI 80264 C FI80264 C FI 80264C FI 854335 A FI854335 A FI 854335A FI 854335 A FI854335 A FI 854335A FI 80264 C FI80264 C FI 80264C
Authority
FI
Finland
Prior art keywords
dihydro
inden
compound
imidazole
methyl
Prior art date
Application number
FI854335A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI854335A7 (fi
FI854335A0 (fi
FI80264B (fi
Inventor
Arto Johannes Karjalainen
Raimo Einari Virtanen
Arja Leena Karjalainen
Kauko Oiva Antero Kurkela
Original Assignee
Farmos Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmos Oy filed Critical Farmos Oy
Publication of FI854335A0 publication Critical patent/FI854335A0/fi
Publication of FI854335A7 publication Critical patent/FI854335A7/fi
Priority to FI882242A priority Critical patent/FI80880C/fi
Priority to FI882241A priority patent/FI81093C/fi
Publication of FI80264B publication Critical patent/FI80264B/fi
Application granted granted Critical
Publication of FI80264C publication Critical patent/FI80264C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Lubricants (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Resins (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Dental Preparations (AREA)
  • Golf Clubs (AREA)
FI854335A 1984-11-23 1985-11-05 Foerfarande foer framstaellning av terapeutiskt aktiva imidazolderivat, som aer substituerade med en bisyklisk grupp i 4(5)-staellning. FI80264C (fi)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI882242A FI80880C (fi) 1984-11-23 1988-05-13 Nya 4(5)-substituerade imidazolderivat, som aer anvaendbara som mellanprodukter.
FI882241A FI81093C (fi) 1984-11-23 1988-05-13 Nya som mellanprodukter anvaendbara 4(5)-(2,3-dihydro-1-oxi-1h-inden-2-yl)-imidazolderivat.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB08429578A GB2167408B (en) 1984-11-23 1984-11-23 Substituted imidazole derivatives and their preparation and use
GB8429578 1984-11-23

Publications (4)

Publication Number Publication Date
FI854335A0 FI854335A0 (fi) 1985-11-05
FI854335A7 FI854335A7 (fi) 1986-05-24
FI80264B FI80264B (fi) 1990-01-31
FI80264C true FI80264C (fi) 1990-05-10

Family

ID=10570140

Family Applications (1)

Application Number Title Priority Date Filing Date
FI854335A FI80264C (fi) 1984-11-23 1985-11-05 Foerfarande foer framstaellning av terapeutiskt aktiva imidazolderivat, som aer substituerade med en bisyklisk grupp i 4(5)-staellning.

Country Status (26)

Country Link
US (1) US4689339A (OSRAM)
EP (2) EP0183492B1 (OSRAM)
JP (1) JPH064597B2 (OSRAM)
KR (1) KR930004673B1 (OSRAM)
AT (2) ATE85050T1 (OSRAM)
AU (2) AU586839B2 (OSRAM)
BG (1) BG60762B2 (OSRAM)
CA (1) CA1268770C (OSRAM)
DD (1) DD258230A1 (OSRAM)
DE (2) DE3587045T2 (OSRAM)
DK (2) DK164903C (OSRAM)
ES (2) ES8704462A1 (OSRAM)
FI (1) FI80264C (OSRAM)
GB (1) GB2167408B (OSRAM)
GR (1) GR852817B (OSRAM)
HK (1) HK3592A (OSRAM)
HU (1) HU195189B (OSRAM)
IE (1) IE58165B1 (OSRAM)
IL (1) IL77111A (OSRAM)
NO (1) NO166585C (OSRAM)
NZ (1) NZ214258A (OSRAM)
PH (1) PH22016A (OSRAM)
PT (1) PT81542B (OSRAM)
SG (1) SG106891G (OSRAM)
SU (1) SU1424736A3 (OSRAM)
ZA (1) ZA858942B (OSRAM)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0252162A4 (en) * 1986-01-28 1988-07-29 Mitsui Petrochemical Ind PROCESS FOR THE PREPARATION OF NON-SUBSTITUTED 2-IMIDAZOLES.
FI81092C (fi) * 1986-05-15 1990-09-10 Farmos Oy Foerfarande foer framstaellning av terapeutiskt aktiva 4(5)-(2,3-dihydro-1h-inden-2-yl)-imidazolderivat.
FI862039A0 (fi) * 1986-05-15 1986-05-15 Farmos Oy Nytt foerfarande foer framstaellning av 4(5)-substituerade imidazolderivat.
JP2576493B2 (ja) * 1987-03-20 1997-01-29 アイシン精機株式会社 原稿読取り装置に用いられる原稿トレ−
FR2621327B1 (fr) * 1987-10-06 1990-01-05 Commissariat Energie Atomique Procede de production et d'extraction de polysaccharides a partir d'une culture de porphyridium cruentum et dispositif pour la mise en oeuvre du procede
GB2225782A (en) * 1988-12-09 1990-06-13 Farmos Group Limited Imidazole derivatives useful for treatment of diabetes
GB8903437D0 (en) * 1989-02-15 1989-04-05 Erba Carlo Spa Imidazolyl derivatives of 3,4-dihydro-2h-1-benzothiopyran
CA1321751C (en) * 1989-02-21 1993-08-31 Eugene C. Crichlow Mechanism mediating ruminal stasis in ruminal lactic acidosis
DK344489D0 (da) * 1989-07-12 1989-07-12 Novo Nordisk As Substituerede 2-imidazoliner og fremstilling og anvendelse deraf
GB2244431A (en) * 1990-05-31 1991-12-04 Farmos Oy Treatment of age related memory impairment and other cognitive disorders
GB2256135B (en) 1991-05-31 1995-01-18 Orion Yhtymae Oy Transdermal administration of 4-substituted imidazoles
US5541211A (en) * 1991-06-18 1996-07-30 Orion-Yhtyma Oy Administration of atipamezole to elicit a yohimbine-like alpha-adrenoreceptor antagonistic noradrenergic transmission
ES2164054T3 (es) * 1991-11-05 2002-02-16 Smithkline Beecham Corp Antagonistas de receptores de endotelina.
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
GB9127430D0 (en) * 1991-12-27 1992-02-19 Scras Benzofuranylimidazole derivatives
GB9312669D0 (en) * 1993-06-18 1993-08-04 Orion Yhtymae Oy New opticla isomers
GB9425211D0 (en) * 1994-12-14 1995-02-15 Ucb Sa Substituted 1H-imidazoles
FR2733983B1 (fr) * 1995-05-10 1997-08-01 Pf Medicament Procede de preparation d'un derive d'acide benzofurane carboxylque optiquement pur et son utilisation pour preparer l'efaroxan
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
FR2754709B1 (fr) 1996-10-23 1999-03-05 Sanofi Sa Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
WO1998055439A1 (en) * 1997-06-05 1998-12-10 Venantius Limited Indane compounds and their pharmaceutical use
WO1999051593A1 (en) * 1998-04-02 1999-10-14 Ortho-Mcneil Pharmaceutical, Inc. 4-thionaphthyl-1h-imidazoles with alpha-2-adrenergic activity
FR2784989B1 (fr) * 1998-09-10 2002-09-27 Fabre Pierre Sante Derive d'ester d'acide 2-ethyl-2,3-dihydrobenzofurane- carboxylique, procede de preparation et utilisation pour la preparation de derives de l'efaroxan
WO2000042023A1 (en) * 1999-01-18 2000-07-20 Novo Nordisk A/S Substituted imidazoles, their preparation and use
US6388090B2 (en) 2000-01-14 2002-05-14 Orion Corporation Imidazole derivatives
US6593324B2 (en) 2000-03-01 2003-07-15 Orion Corporation Dervatives of quinoline as alpha-2 antagonists
ATE302757T1 (de) 2000-05-08 2005-09-15 Orion Corp Neue polyzyklische indanylimidazole mit alpha2 adrenergik aktivität
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US6543389B2 (en) 2001-06-26 2003-04-08 Pfizer Inc. Insecticidal pet collar
CA2480695A1 (en) 2002-04-03 2003-10-09 Orion Corporation Polycyclic compounds as potent alpha2-adrenoceptor antagonists
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
FI116292B (fi) * 2003-01-08 2005-10-31 Juvantia Pharma Ltd Oy Menetelmä substituoitujen imidatsolijohdannaisten valmistamiseksi ja menetelmässä käytettäviä välituotteita
ES2315740T3 (es) * 2003-11-04 2009-04-01 Intervet International Bv Formulaciones ectoparasiticidas de espinosinas y pesticidas de azol.
FI20050657A0 (fi) * 2005-06-17 2005-06-17 Orion Corp Atipametsolin kiteytysmenetelmä
CA2624788C (en) 2005-10-12 2011-04-19 Unimed Pharmaceuticals, Llc Improved testosterone gel and method of use
US7592461B2 (en) 2005-12-21 2009-09-22 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
WO2008017591A1 (en) * 2006-08-08 2008-02-14 Intervet International B.V. Composition for enhanced antiparasitic activity
TWI457122B (zh) 2007-07-20 2014-10-21 Orion Corp 作為用於治療周邊和中央神經系統疾病之alpha2C拮抗劑的2,3－二氫苯並[1,4]戴奧辛－2－基甲基衍生物
CL2008003553A1 (es) * 2007-12-05 2009-11-27 Grindeks Jsc Proceso para preparar atipamezol o clorhidrato de 5-(2-etil-2,3-dihidro-1h-inden-2-il)-1h-imidazol: y loa compuestos intermediarios considerados en el proceso
CR20160214A (es) 2013-11-05 2016-10-11 3M Innovative Properties Co Formulaciones de inyección con base en aceite de sésamo
TWI704145B (zh) 2015-06-05 2020-09-11 芬蘭商奧利安公司 新醫藥化合物
EP3370718B1 (en) 2015-11-05 2021-01-27 University Of Louisville Research Foundation, Inc. Local and regional anesthesia and analgesia
JP2019519582A (ja) 2016-06-29 2019-07-11 オリオン コーポレーション ベンゾジオキサン誘導体およびその医薬用途
CN113194750A (zh) 2018-12-21 2021-07-30 雀巢产品有限公司 用于在婴儿或幼儿中引起饱腹感、更好的睡眠和/或限制夜间觉醒的营养组合物
CN111978254A (zh) * 2019-05-22 2020-11-24 南京康德祥医药科技有限公司 一种阿替美唑盐酸盐的制备工艺
CN111925330A (zh) * 2020-09-07 2020-11-13 上海阿达玛斯试剂有限公司 一种阿替美唑的制备方法
EP4658639A1 (en) 2023-02-01 2025-12-10 Univerza V Ljubljani N,n-dialkyl-4-(2-ethylindan-2-yl)-1h-imidazole-1-carboxamides and related compounds for treatment of neurodegenerative diseases
LU103072B1 (en) 2023-02-15 2024-08-19 Univ Ljubljani N,N-DIALKYL-4-(2-ETHYLINDAN-2-YL)-lH-IMIDAZOLE-l-CARBOXAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2933962A1 (de) * 1979-08-22 1981-03-26 Hoechst Ag, 65929 Frankfurt Verfahren zur herstellung von 4,5-dichlor-imidazolen.
US4342775A (en) * 1980-03-04 1982-08-03 Farmitalia Carlo Erba S.P.A. 3-(1-Imidazolyl)-derivatives of 2,3-dihydro-4H-1-benzopyran
US4302469A (en) * 1980-09-10 1981-11-24 Syntex (U.S.A.) Inc. 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles useful as antidepressants
NZ201219A (en) * 1981-07-28 1984-10-19 Reckitt & Colmann Prod Ltd Dihydrobenzofuranyl-2-imidazolines and pharmaceutical compositions
ES8503669A1 (es) * 1982-07-05 1985-03-01 Erba Farmitalia Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos.
FR2539415B1 (fr) * 1983-01-14 1985-09-13 Adir Derives de la d-2 imidazoline, leur preparation et leur application en therapeutique
FR2542738A1 (fr) * 1983-03-18 1984-09-21 Synthelabo Indanyl-2 d2-imidazoline, procede pour la preparer, et compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
JPH064597B2 (ja) 1994-01-19
FI854335A7 (fi) 1986-05-24
EP0183492A1 (en) 1986-06-04
EP0310745B1 (en) 1993-01-27
HK3592A (en) 1992-01-17
ATE47997T1 (de) 1989-12-15
BG60762B2 (bg) 1996-02-29
KR860004028A (ko) 1986-06-16
ATE85050T1 (de) 1993-02-15
ZA858942B (en) 1986-08-27
SU1424736A3 (ru) 1988-09-15
CA1268770C (en) 1990-05-08
AU5008385A (en) 1986-05-29
GB2167408A (en) 1986-05-29
PT81542B (pt) 1988-03-03
ES549178A0 (es) 1987-04-01
HU195189B (en) 1988-04-28
IL77111A (en) 1989-09-28
FI854335A0 (fi) 1985-11-05
DK58292D0 (da) 1992-05-04
ES557268A0 (es) 1987-12-16
AU586839B2 (en) 1989-07-27
NO166585C (no) 1991-08-21
DK540485A (da) 1986-05-24
US4689339A (en) 1987-08-25
EP0183492B1 (en) 1989-11-15
NO166585B (no) 1991-05-06
CA1266669A1 (en) 1990-03-13
GB2167408B (en) 1988-05-25
KR930004673B1 (ko) 1993-06-03
AU3332989A (en) 1989-08-10
EP0310745A3 (en) 1989-10-11
GB8429578D0 (en) 1985-01-03
GR852817B (OSRAM) 1986-03-21
DK58292A (da) 1992-05-04
HUT38913A (en) 1986-07-28
EP0310745A2 (en) 1989-04-12
ES8801248A1 (es) 1987-12-16
ES8704462A1 (es) 1987-04-01
IL77111A0 (en) 1986-04-29
DE3587045D1 (de) 1993-03-11
IE58165B1 (en) 1993-07-28
DK164903B (da) 1992-09-07
NZ214258A (en) 1989-02-24
DK540485D0 (da) 1985-11-22
FI80264B (fi) 1990-01-31
JPS61143366A (ja) 1986-07-01
IE852929L (en) 1986-05-23
DE3587045T2 (de) 1993-06-03
PT81542A (en) 1985-12-01
NO854671L (no) 1986-05-26
PH22016A (en) 1988-05-13
DK164903C (da) 1993-01-25
SG106891G (en) 1992-02-14
DD258230A1 (de) 1988-07-13
DE3574252D1 (en) 1989-12-21

Similar Documents

Publication Publication Date Title
FI80264C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva imidazolderivat, som aer substituerade med en bisyklisk grupp i 4(5)-staellning.
JP4129891B2 (ja) α２受容体活性に親和性を有するイミダゾール誘導体
EP0760811A1 (fr) Derives d'imidazole (ant)agonistes du recepteur h 3? de l'histamine
FI81092C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 4(5)-(2,3-dihydro-1h-inden-2-yl)-imidazolderivat.
Langlois et al. Design and synthesis of new naphthalenic derivatives as ligands for 2-[125I] iodomelatonin binding sites
FI67545B (fi) Foerfarande foer framstaellning av ett farmakologiskt aktivt imidazolinderivat
FI96026C (fi) Menetelmä terapeuttisesti tehokkaiden 4(5)-asemassa bisyklisellä ryhmällä substituoitujen imidatsolien valmistamiseksi
ZA200504145B (en) Novel benzopyran analogs and their use for the treatment of glaucoma
FI80879C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 4(5)-(2,3-dihydro-1h-inden-2-yl)-imidazolderivat.
CA1268770A (en) Preparation of imidazole derivatives
McCarthy et al. Synthesis and renal vasodilator activity of 2-chlorodopamine and N-substituted derivatives
FI59586C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla bens-1,2-isoxazolfoereningar
NZ226305A (en) Substituted imidazoles

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: ORION-YHTYMAE OY

FG Patent granted

Owner name: ORION-YHTYMAE OY

MA Patent expired